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The explosive increase in the number of drugs offered for therapy has
had many consequences, one of which is to increase the amount of testing
that must be done in man. The large number of such studies makes it more
urgent that the physician be reminded of his responsibilities in such a pro-
gram and that he be knowledgeable about the methods for carrying out
clinical trials so that the fewest number of patients can yield the greatest
amount of valid information with minimum risk, discomfort, and expense.
In view of the flood of drugs submitted to clinical trial during the past
fifteen years, it is a tribute to the restraint and intelligence of the clinical
investigators (with considerable help from man's natural gift for survival)
that iatrogenic diseases are not more frequent and that there have not been
more unconfirmable therapeutic successes.
Certainly what has been needed is a modern, authoritative, and scholarly
account of the clinical evaluation of drugs, a book which suits the need of
the investigator and at the same time points out to all physicians the stand-
ards by which they must evaluate clinical reports.
Happily, this book has arrived. It has succeeded in presenting in a
scholarly way the planning, technique, sources of error, and the variables
encountered in evaluating drugs in man. It is emphatically not a "how to"
book. Rather, a group of experienced and thoughtful investigators have
written chapters on various aspects of drug-testing, presenting broad gen-
eral principles with pertinent examples to make their points more vivid.
The book is divided into two parts. Part one begins with articles on
pharmacological problems in studies on lower animals through the initia-
tion of studies in man. Chapters on experimental design and statistics and
placebos follow. Discussions of the ethics of experimentation on human
beings, human beings as experimental subjects, the investigator himself,
and the training of an investigator complete the first part of the book. The
second section comprises six chapters on a selected group of disorders:
infectious diseases; cardiovascular disorders; gastrointestinal diseases; nu-
trition and metabolism; endocrinologic problemns; and neuropsychiatric dis-
orders. The volume ends with a short article on the problems of publica-
tion. All the chapters in the second section are brief but they serve to
demonstrate the common experiences and the wide areas of agreement of
the authors.
Contributors are Karl H. Beyer, Elmer L. Severinghaus, Louis Lasagna,
Paul Meier, Henry K. Beecher, William B. Bean, Stewart Wolf, Dwight
J. Ingle, Harry F. Dowling, Thomas E. Machella, J. Lester Gabrilove,
Nathan S. Kline, and both editors. The book is exceedingly well written.
All physicians and medical students should read this, not once but sev-
eral times. It will never fail to sharpen the reader's critical sense. It not
only shows the complexities inherent in evaluating therapy but is itself
sobering prophylaxis for the present therapeutic binge.
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